8 employees
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.
2021
$14M
from 2 investors over 2 rounds
Corteria Pharmaceuticals raised $14M on December 9, 2021
Investors: Omnes and V-Bio Ventures